European Journal of Medicinal Chemistry p. 291 - 300 (1996)
Update date:2022-08-02
Topics:
Balsamo
Breschi
Chiellini
Cozzini
Domiano
Macchia
Manera
Martinelli
Nencetti
Rossello
Sacca
Scatizzi
The chiral N-isopropyl- and N-t-butyl-substituted 2-(3′-(5′-p-chlorophenyl)isoxazolidinyl)ethanolamines 2, 3, which can be viewed as conformationally restrained analogs of the corresponding methyloxyiminomethyl (MOIM) β-adrenergic antagonists 1, were synthesized from optically active precursors with a known absolute configuration. The structure and configuration of the intermediate and final products 2, 3 were assigned on the basis of a comparison of the 1H-NMR spectral data of all compounds, crystallographic analysis of one of the intermediates [(2R,5′S)-7] and knowledge of the configuration of the chiral starting compounds 4. The new isoxazoline derivatives 2, 3 were tested for their affinity towards β1- and β2-adrenoceptors by radioligand binding experiments; compounds showing affinity indices lower than 10 μM on β1-adrenoceptors were also assayed for their β-adrenergic activity by functional tests on isolated preparations. The results showed that the cyclic derivatives 2, 3 possess a capacity to interact with β-receptors which is clearly lower than that of the corresponding MOIM analogs 1.
View MoreContact:+86 021-51698675
Address:1701, Jielong Plaza, No.618 Pingliang Rd, ShangHai,China
Contact:021-36356756
Address:Room601,Building No.14,280 Yangcheng Road,Shanghai
Henan PURUI Pharmaceutical Co., Ltd.
website:http://www.puruipharm.com
Contact:17739583555
Address:Yezhuangqiao,Xihua town, Henan province
ShangHai Original Economy-Trade Develop Co.,Ltd.,
Contact:86-21-68552131
Address:shanghai
Refine Chemicals Science & Technology Technology Developing Co., Ltd.
Contact:+86-22-87899130
Address:No.12,west keyan road,Tianjin City
Doi:10.1016/0040-4039(96)00774-5
(1996)Doi:10.1080/00397911.2015.1092552
(2015)Doi:10.1021/ol035365d
(2003)Doi:10.1021/jo9604292
(1996)Doi:10.1021/jm970872k
(1998)Doi:10.1016/0022-328X(95)05586-0
(1995)